BUZZ-U.S. STOCKS ON THE MOVE-Fluidigm, Flex Pharma, Contravir Pharma
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)
The S&P 500 and the Dow Jones Industrial average touched three-month lows on Thursday, dragged down by weak Chinese economic data and the prospects of a U.S. interest rate hike by the end of the year.
The Dow Jones Industrial Average was down 0.18 percent at 18,111.91, the S&P 500 was down 0.19 percent at 2,135.08 and the Nasdaq Composite was down 0.38 percent at 5,219.081.
** FLUIDIGM CORP, $5.05, -28.37 pct
The life sciences research company estimated a 23 percent drop in third-quarter revenue due to lower-than-expected sales of Helios systems.
** FLEX PHARMA INC, $8.92, -20.36 pct
Prelim analysis of trial data on Flex's experimental nocturnal leg cramps drug showed that it did not confer a statistically significant benefit on muscle-cramp frequency. Continued...